The cycle of innovation in life science research is accelerating as developments in molecular tools, automation and AI combine to reveal new treatment pathways, drugs and diagnostic biomarkers.

Join Amati managers Graeme Bencke and Mikhail Zverev as they consider the implications for the enablers of this innovation, from lab equipment to clinical trials to healthcare robotics.

⚠️ Warning: Capital at Risk. Professional Investors Only.